Health Everolimus Fails Again as Adjuvant Therapy for High-Risk Breast Cancer Eli Pacheco Dec 9, 2022 0 SAN ANTONIO -- A second randomized trial failed to show a benefit of adding everolimus (Afinitor) to adjuvant endocrine therapy…
Health Adjuvant Everolimus Fails to Stop Recurrence in Early High-Risk Breast Cancer Eli Pacheco Jun 2, 2022 0 Adding mTOR inhibitor everolimus (Afinitor) to adjuvant endocrine therapy failed to improve…